Soros Fund Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Soros Fund Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1	Closed	–	–	341
2022 Q3	$0	Buy	+1	New	+$55	﹤0.01%	298
2016 Q1	–	Sell	-21,000	Closed	-$679K	–	331
2015 Q4	$679K	Hold	21,000	–	–	0.01%	176
2015 Q3	$885K	Buy	+21,000	New	+$991K	0.01%	189

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Soros Fund Management's GBT Position: Q4 2022 in Review

Soros Fund Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 1 share.

Soros Fund Management first reported a position in GBT in Q3 2015 and held it in 3 quarters. The position peaked at $885K in Q3 2015. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Soros Fund Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Soros Fund Management sold 1 Global Blood Therapeutics, Inc. share in Q4 2022.
Soros Fund Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 3 quarters.
Soros Fund Management's Global Blood Therapeutics, Inc. position peaked at $885K in Q3 2015.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Soros Fund Management's 13F filing for Q4 2022, filed 13 Feb 2023.